NASDAQ:NAKA · NASDAQ Global Market
+$0.00 today
Vol 0.22M · Avg 0.24M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $35.3M |
| Receivables | $5.9M |
| Other Current | $22.2M |
| Total Current Assets | $63.4M |
| Goodwill | $93.5M |
| Intangible Assets | $446.8M |
| Long-term Investments | $16.9M |
| Other Non-current | $186.0K |
| Total Non-current Assets | $557.3M |
| Total Assets | $620.8M |
Analysis
Selected assets total $620.8M for Latest. The largest visible component is Intangible Assets at $446.8M, about 72.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Assets
—
Liabilities
—
Equity
—
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22.6M +893.3% | $2.3M +332.7% | $525.5K +181.1% | $186.9K +97.4% | $94.7K | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $2.8K -92.4% | $36.9K +31.6% | $28.0K +131.0% | $12.1K -10.0% | $13.5K | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 -100.0% | $4.3K -93.2% | $63.2K +27.5% | $49.6K -17.1% | $59.8K | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $199.1M | $0 -100.0% | $225 -99.6% | $61.0K -39.9% | $101.5K | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $223.8M +8832.5% | $2.5M +306.1% | $616.9K +99.3% | $309.6K +14.9% | $269.4K | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $0 -100.0% | $764.6K +62.3% | $471.0K -24.4% | $622.9K +263.1% | $171.6K | $1.2B | $1.5B | $687.8M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $470.6M +121072.5% | $388.3K | $0 | $0 | $0 | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $35.7M | $0 | $0 | $0 -100.0% | $6.6K | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $534.3K +2650.4% | $19.4K +72.3% | $11.3K -22.3% | $14.5K | $0 | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $506.8M +43129.0% | $1.2M +143.1% | $482.3K -24.3% | $637.4K +257.7% | $178.2K | -$15.3B | $14.8B | $11.3B |
| Total Assets | $730.6M +19764.3% | $3.7M +234.6% | $1.1M +16.1% | $947.0K +111.6% | $447.6K | $13.3B | $11.9B | $10.6B |
| Account Payables | $5.9M +1710.0% | $323.7K | $0 | $0 -100.0% | $47.5K | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $209.6M +150361.0% | $139.3K -6.2% | $148.5K +60.5% | $92.5K +72.8% | $53.5K | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 -100.0% | $2.3K -33.6% | $3.4K -60.2% | $8.6K -50.1% | $17.3K | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $568.2K | $0 -100.0% | $567.8K +241.5% | $166.3K | $0 | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $216.0M +35538.2% | $606.0K -25.6% | $814.4K +148.4% | $327.9K +177.2% | $118.3K | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $0 | $0 -100.0% | $228.9K | $0 | $0 | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $0 | $0 | $0 | $0 | $0 | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $366.0K -27.3% | $503.6K +28.1% | $393.2K +65.1% | $238.1K +323.1% | $56.3K | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $216.4M +19396.7% | $1.1M -8.1% | $1.2M +113.4% | $566.0K +224.2% | $174.6K | $14.7B | $3.7B | $9.6B |
| Common Stock | $439.9K +7171.9% | $6.0K +31.0% | $4.6K +4.1% | $4.4K -98.4% | $273.1K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$60.0M -671.7% | -$7.8M -87.0% | -$4.2M -63.7% | -$2.5M | $0 | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $514.3M +19923.2% | $2.6M +2469.0% | -$108.4K -128.5% | $381.0K +39.5% | $273.1K | $9.1B | $7.7B | $3.3B |
| Total Debt | $209.9M +26686.8% | $783.7K +23.1% | $636.4K +62.7% | $391.1K +256.2% | $109.8K | $724.2M | $410.6M | $399.4M |
| Net Debt | $187.3M +12673.7% | -$1.5M -1443.8% | $110.9K -45.7% | $204.2K +1250.4% | $15.1K | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Agilon Health, Inc.
NYSE:AGL
$1.85B
Delcath Systems, Inc.
NASDAQ:DCTH
$455.69M
DBV Technologies S.A.
NASDAQ:DBVT
$378.44M
Simulations Plus, Inc.
NASDAQ:SLP
$371.58M
SOPHiA GENETICS S.A.
NASDAQ:SOPH
$367.75M
Amarin Corporation plc
NASDAQ:AMRN
$338.58M
Cellectis S.A.
NASDAQ:CLLS
$331.38M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$327.84M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$278.98M
Definitive Healthcare Corp.
NASDAQ:DH
$82.28M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does NAKA have?
Nakamoto Inc. (NAKA) reported $22.58M in cash and equivalents in fiscal 2025.
How much debt does NAKA carry?
Nakamoto Inc. (NAKA) reported $209.92M of total debt, with net debt of $187.34M.
Explore More
Continue the stock analysis
Jump to another research area for this company.